10:48 AM EST, 12/06/2024 (MT Newswires) -- CERo Therapeutics Holdings ( CERO ) said Friday it appointed Chris Ehrlich as permanent chief executive, effective immediately.
Ehrlich previously held the interim CEO role at the company.
Shares of CERo Therapeutics ( CERO ) slumped past 32% in recent trading.
Price: 0.13, Change: -0.06, Percent Change: -32.06